/

Parabilis Medicines

Developing helical peptide therapeutics for undruggable cancer targets.

BiotechnologyPharmaceuticals parabilismed.com ↗

Company facts

Founded: 2015
Employees: 176
Headquarters: United States
Type: Private
Funding: Series F · $305M · 2026